Docetaxel in combination with epirubicin in metastatic breast cancer: pharmacokinetic interactions. | Farmaco;54(11-12): 733-9, 1999. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Docetaxel in combination with epirubicin in metastatic breast cancer: pharmacokinetic interactions.

Ceruti, M; Tagini, V; Recalenda, V; Arpicco, S; Cattel, L; Airoldi, M; Bumma, C.

Affiliation

Ceruti M; Dipartimento di Scienza e Tecnologia del Farmaco, Università di Torino, Turin, Italy.

Farmaco ; 54(11-12): 733-9, 1999.

Article in En | MEDLINE | ID: mdl-10668172

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Taxoids Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Farmaco Journal subject: FARMACOLOGIA / QUIMICA Year: 1999 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Taxoids Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Farmaco Journal subject: FARMACOLOGIA / QUIMICA Year: 1999 Document type: Article Affiliation country: Country of publication: